Transition-State-Guided Strategies in Natural Product-Based Drug Design
| dc.contributor.author | Tharindu Senapath | |
| dc.date.accessioned | 2026-09-25T07:02:39Z | |
| dc.date.available | 2026-09-25T07:02:39Z | |
| dc.date.issued | 2026-01 | |
| dc.description | p.13 -15 | |
| dc.description.abstract | For over a century, natural products have played a pivotal role in modern medicine, serving as sources of essential drugs for the treatment of infectious, oncological, metabolic, and neurological disorders. These compounds have evolved in plants, microbes, and animals to interact specifically with biological targets | |
| dc.identifier.issn | ISSN 1012 - 8999 | |
| dc.identifier.uri | https://dr.ichemc.ac.lk/handle/123456789/507 | |
| dc.language.iso | en | |
| dc.publisher | Institute of Chemistry Ceylon | |
| dc.relation.ispartofseries | 43; 1 | |
| dc.subject | Drug Design | |
| dc.subject | Natural Product | |
| dc.title | Transition-State-Guided Strategies in Natural Product-Based Drug Design | |
| dc.type | Article |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: